Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126782522 | 12678252 | 2 | F | 20160829 | 20160823 | 20160902 | EXP | HK-MYLANLABS-2016M1035354 | MYLAN | YEUNG TLM, LI PSH, LI KKW. PRESUMED TOPIRAMATE RETINOPATHY: A CASE REPORT. J-MED-CASE-REP 2016;(210):210. DAT. | 0.00 | Y | 0.00000 | 20160902 | OT | HK | HK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126782522 | 12678252 | 1 | PS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | LATER, THE DOSE WAS INCREASED TO 100 MG TWICE A DAY | Y | U | 76314 | 25 | MG | BID | |||||
| 126782522 | 12678252 | 2 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | Y | U | 76314 | 100 | MG | BID | ||||||
| 126782522 | 12678252 | 3 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126782522 | 12678252 | 1 | Seizure |
| 126782522 | 12678252 | 3 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126782522 | 12678252 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126782522 | 12678252 | Retinopathy | |
| 126782522 | 12678252 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |